EGI
IMGN

EAM Global Investors’s Immunogen Inc IMGN Stock Holding History

EAM Global Investors’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-218,776
Closed -$4.13M – 142
2023
Q2 		$4.13M Buy
+218,776
New +$2.58M 1.21% 44
2018
Q2 		– Sell
-141,737
Closed -$1.49M – 192
2018
Q1 		$1.49M Buy
+141,737
New +$1.4M 0.77% 24

Other funds holding IMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

EAM Global Investors's IMGN Position: Q3 2023 in Review

EAM Global Investors sold out of Immunogen Inc (IMGN) in Q3 2023, closing a stake of 218,776 shares — an estimated $4.13M sold.

EAM Global Investors first reported a position in IMGN in Q1 2018 and held it in 2 quarters. The position peaked at $4.13M in Q2 2023. 275 funds tracked by Wall St. Rank hold IMGN as of Q3 2023.

  • EAM Global Investors reported no remaining Immunogen Inc position as of Q3 2023 after selling out during the quarter.
  • EAM Global Investors sold 218,776 Immunogen Inc shares in Q3 2023, an estimated $4.13M.
  • EAM Global Investors first reported a position in Immunogen Inc in Q1 2018 and held it in 2 quarters.
  • EAM Global Investors's Immunogen Inc position peaked at $4.13M in Q2 2023.
  • 275 funds tracked by Wall St. Rank held Immunogen Inc as of Q3 2023.

Based on EAM Global Investors's 13F filing for Q3 2023, filed 13 Nov 2023.